Related Experiment Video
Updated: Jul 19, 2026

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
Published on: April 3, 2016
Ocular axial length changes in pseudophakic children after traumatic and congenital cataract surgery
Hana Leiba1, Amira Springer, Ayala Pollack
1Department of Ophthalmology, Kaplan Medical Center, Rehovot, Israel. leiba3@bezeqint.net
Insights
Pseudophakic children experienced greater axial length increase compared to non-operated eyes. This axial elongation was more pronounced in younger children (under 5) undergoing cataract surgery.
Area of Science:
- Ophthalmology
- Pediatric Ophthalmology
- Biomedical Engineering
Background:
- Pseudophakic children often exhibit significant myopic shifts.
- Accelerated axial length growth is a potential contributor to this myopic shift.
- Understanding axial length changes is crucial for managing visual development in these children.
Purpose of the Study:
- To evaluate and compare the postoperative change in axial length (DeltaAL) in pseudophakic eyes.
- To compare axial length changes after traumatic versus congenital cataract extraction in children.
- To investigate the influence of age at operation on axial elongation.
Main Methods:
- Retrospective study of 20 children under 10 years old who underwent cataract surgery.
- Axial length (AL) measured perioperatively and at least 1 year postoperatively.
- Comparison of DeltaAL between operated and fellow non-operated eyes, stratified by age and cataract type.
Main Results:
- Operated eyes showed a trend towards greater axial elongation than fellow eyes (p=0.06 for traumatic, p=0.055 for unilateral congenital cataracts).
- Axial elongation was significantly greater in children operated on before age 5 (p=0.025).
- The rate of DeltaAL was similar between traumatic and unilateral congenital cataract groups.
Conclusions:
- Pseudophakic eyes in children tend to exhibit greater axial lengthening compared to their non-operated fellow eyes.
- No significant difference in the tendency for increased axial lengthening was observed between eyes operated for traumatic versus congenital cataracts.
- Age at the time of surgery is a significant factor influencing axial elongation in pseudophakic children.
Background:
Pseudophakic children tend to develop a large myopic shift. This may be in part due to accelerated growth in axial length. The purpose of this study was to evaluate and compare the postoperative change in axial length (DeltaAL) in pseudophakic eyes, after extraction of traumatic or congenital cataract.
Methods:
Included in this retrospective study were 20 children who had undergone surgery for traumatic, unilateral congenital, or bilateral congenital cataracts. All patients were under 10 years old at the time of operation. Axial length was measured perioperatively as well as 1 year or more postoperatively. The three groups were subdivided according to patients' ages (below or above 5 years). The DeltaAL in the operated eyes was compared with DeltaAL of the fellow nonoperated eyes. The difference in DeltaAL between operated and fellow nonoperated eyes was compared among the groups.
Results:
DeltaAL was greater for operated eyes than for fellow nonoperated eyes (traumatic cataract: p=0.06; unilateral congenital cataract, p=0.055). Axial elongation was significantly greater in children under 5 years old at operation than in those older than 5 (p=0.025). The difference in rate of DeltaAL between operated and fellow nonoperated eyes, per 1 year of follow-up, was similar for traumatic and unilateral congenital cataract groups.
Conclusions:
This study demonstrated a tendency toward greater axial lengthening in pseudophakic eyes of children, when compared with their nonoperated eyes. No significant difference was found in the tendency for increased axial lengthening between eyes operated on for traumatic cataracts and those operated on for congenital cataracts.
Related Concept Videos
Glaucoma: Overview
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...